That's a very good question.
Passing the bill in its current form would mean that the minister did not have the necessary tools to act quickly when a serious health risk was identified. I'll give you two tools.
Ordering a mandatory recall is one of those tools. When we order a mandatory recall, it means that we have already asked the party concerned to recall the product voluntarily, so this is really a measure of last resort. However, it's an important one. We need a way to act when we don't get the necessary level of co‑operation.
Seeking an injunction is the other post-market tool that can be used. If someone is asked to stop selling a product and simply disregards the request, we can turn to the courts, which have additional tools to really manage the risk.
That's more on the operational side.
The other distinction when it comes to the bill is that, within the regulations, there are flexible regulatory tools. Those are necessary to support our efforts to modernize processes and reduce the burden on industry, which I mentioned earlier. Without those tools, we won't be able to do our work quickly, and that would be unfortunate for the industry.
